{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:48:12Z","timestamp":1761598092954,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijbiomac.2019.06.233","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:11:30Z","timestamp":1562238690000},"page":"790-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax"],"prefix":"10.1016","volume":"137","author":[{"given":"Ying","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/mmi.13465","article-title":"Flying under the radar: the non-canonical biochemistry and molecular biology of petrobactin from Bacillus anthracis","volume":"102","author":"Hagan","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/523578","article-title":"Vaccines: countering anthrax: vaccines and immunoglobulins","volume":"46","author":"Grabenstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0015","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cid\/ciw184","article-title":"Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880","volume":"62","author":"Katharios-Lanwermeyer","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005","volume":"144","author":"Holty","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0025","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vaccine.2015.11.025","article-title":"Neutralizing antibody and functional mapping of bacillus anthracis protective antigen-the first step toward a rationally designed anthrax vaccine","volume":"34","author":"McComb","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1586\/14760584.2016.1162104","article-title":"Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less","volume":"15","author":"Schiffer","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fmicb.2015.01009","article-title":"Anthrax prophylaxis: recent advances and future directions","volume":"6","author":"Williamson","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/CVI.00320-13","article-title":"Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactions","volume":"20","author":"Watkinson","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yrtph.2017.09.003","article-title":"Investigating toxicity specific to adjuvanted vaccines","volume":"91","author":"Matsumoto","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coi.2017.07.010","article-title":"Towards an evidence based approach for the development of adjuvanted vaccines","volume":"47","author":"O'Hagan","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6445-1_1","article-title":"Overview of vaccine adjuvants: introduction, history, and current status","volume":"1494","author":"Shah","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the adjuvant system story","volume":"13","author":"Garcon","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/CVI.00019-14","article-title":"Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant","volume":"21","author":"Feinen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0085","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2014.09.034","article-title":"Immunogenicity and safety of Advax, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled phase 1 study","volume":"32","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0090","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2016.05.071","article-title":"Human phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant","volume":"34","author":"Gordon","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.1501903","article-title":"A CpG-Ficoll nanoparticle adjuvant for anthrax protective antigen enhances immunogenicity and provides single immunization protection against inhaled anthrax in monkeys","volume":"196","author":"Kachura","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0100","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1021\/bm400930k","article-title":"Engineering biomaterial-associated complement activation to improve vaccine efficacy","volume":"14","author":"Liu","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nantod.2014.10.001","article-title":"Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment","volume":"9","author":"Dewitte","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2017.03.033","article-title":"Synthetic nanovaccines for immunotherapy","volume":"263","author":"Luo","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2010.01.007","article-title":"Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen","volume":"143","author":"Slutter","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/acs.bioconjchem.6b00116","article-title":"A potent antigen-adjuvant delivery system by conjugation of mycobacterium tuberculosis Ag85B-HspX fusion protein with arabinogalactan-poly(I:C) conjugate","volume":"27","author":"Huang","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0125","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.molpharmaceut.6b00138","article-title":"Conjugation with an inulin-chitosan adjuvant markedly improves the immunogenicity of mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"13","author":"Yu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0130","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acs.bioconjchem.7b00131","article-title":"Conjugation reaction with 8-arm PEG markedly improves the immunogenicity of mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"28","author":"Sun","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0135","doi-asserted-by":"crossref","first-page":"a007401","DOI":"10.1101\/cshperspect.a007401","article-title":"Dendritic cells: arbiters of immunity and immunological tolerance","volume":"4","author":"Lewis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0140","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.1500780","article-title":"PU.1 expression in T follicular helper cells limits CD40L-dependent germinal center B cell development","volume":"195","author":"Awe","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cod.12746","article-title":"Detection of local inflammation induced by repeated exposure to contact allergens by use of IVISS pectrum CT analyses","volume":"76","author":"Nielsen","year":"2017","journal-title":"Contact Derm"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1615\/CritRevImmunol.2014012204","article-title":"Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination","volume":"34","author":"van Beek","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2217\/imt.10.56","article-title":"Enhancement of dendritic cells as vaccines for cancer","volume":"2","author":"Turnis","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0170","first-page":"323","article-title":"PEGylation-a well-proven strategy for the improvement of recombinant drugs","volume":"69","author":"Z\u00fcndorf","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0185","doi-asserted-by":"crossref","first-page":"16133","DOI":"10.1021\/la303466w","article-title":"Mechanistic insights into the stabilization of srcSH3 by PEGylation","volume":"28","author":"Meng","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcis.2017.09.027","article-title":"PEGylated magnetic Prussian blue nanoparticles as a multifunctional therapeutic agent for combined targeted photothermal ablation and pH triggered chemotherapy of tumour cells","volume":"509","author":"Xue","year":"2018","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imbio.2013.08.008","article-title":"Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine","volume":"219","author":"Yin","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2019.06.233_bb0200","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1021\/bc7003878","article-title":"PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein","volume":"19","author":"Meng","year":"2008","journal-title":"Bioconjug. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019317787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019317787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:42:38Z","timestamp":1758872558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019317787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0141813019317787"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.233","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}